Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Akers Biosciences, Inc LSE:AKR London Ordinary Share COM SHS NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 130.00p 120.00p 140.00p 130.00p 130.00p 130.00p 0 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2.9 -4.3 -45.2 - 118.23

Akers Biosciences Share Discussion Threads

Showing 3876 to 3899 of 3900 messages
Chat Pages: 156  155  154  153  152  151  150  149  148  147  146  145  Older
DateSubjectAuthorDiscuss
20/11/2018
12:43
MCDid they consolidate 1 for 10?I think they must be confident of a lump out of Aker to hang in there on meagerHeparin
sambocoole
21/10/2018
20:33
" Outlining the Class Action Lawsuit Against Akers Biosciences, Inc. Securities " hTTps://www.youtube.com/watch?v=UnHQ0HYmtyY
algernon2
03/10/2018
22:57
AKR / AKER seem to have re-booted their twitter profiles (ie deleted all the stuff that was previously on them), deleted their facebook profile whilst their linkedin profile doesn't appear to have been updated for a long while.
mcmather
26/9/2018
17:43
Ho Hum! the sound of Tumbleweed blowing through the AKR BB.Not heard anything about the impending lawsuits. Any one any news or thoughts or ideas to add to the mix?
algernon2
11/8/2018
21:46
A bounce from 21 to 28 cents on the nasdaq , may hold a different story . I am a holder for the forseable . Best of All
bbr391
11/8/2018
13:35
Friday , at around 20p a share = £2,600 worth traded = 43.33% rise 21.50 TODAY'S CHANGE 6.50 / 43.33% SHARES TRADED 12.89k
buywell3
10/8/2018
20:59
Highly suspicious past Indeed . The future holds several surprises here . That Is why I am now a long term holder , through these shenanigans . Best of All
bbr391
28/7/2018
12:42
Thanks Buywell,sent them an email yesterday but not holding my breath as they have not replied before when asked on other matters. I did get one reply once a long while ago when I enquired about visiting.
algernon2
28/7/2018
10:01
Good luck with that one
buywell3
27/7/2018
09:49
Yes this class action ongoing re investors who bought shares between certain dates should also include those who owned and held shares during those dates; as we held those shares rather than selling them , based on the same information or disinformation that the buyers may be suing Akers over. Discuss. I would (might have) have sold rather than held if I had access to accurate information and figures earlier; so I have sustained a loss here. Maybe the law firms looking at the issue could cast their nets a bit wider if they believe or can prove "evil" or "skullduggery" or "stupidity and laxness" has been at work. I shall send Akers the suggestion they respond via ADVFN BB to the comments if they have anything to say.
algernon2
27/7/2018
09:40
Today PRICE (GBX) 19.00 TODAY'S CHANGE 1.50 / 8.57% SHARES TRADED 18.58k What a larf
buywell3
26/7/2018
11:19
Akers Biosciences (AKR) News Out Just Now http://crweworld.com/article/news-provided-by-globenewswire/749875/akers-biosciences-announces-lifting-of-temporary-suspension-of-trading-on-the-london-stock-exchange
danieldanj
18/7/2018
13:37
Akers Biosciences (AKR) News Out Just Now http://crweworld.com/article/news-provided-by-globenewswire/740118/akers-biosciences-signs-a-further-independent-sales-representative-organization-for-heparin-pf4-rapid-test-covering-additional-12-states
danieldanj
18/7/2018
10:55
As feared, Gormally seems to have as much of a clue re PIFA Heparin / it's efficacy / selling it / etc as Walt; this is the fella who, following GNYHA having informally given the go ahead for the device to be sold in Puerto Rico, said "release the hounds". A very unusual thing for a grown man - nevermind a CEO - to say in my opinion. This is about the 15th new strategy to try to sell their 'flagship' device.... "....The Company is taking steps to improve its market presence for PIFA Heparin PF/4 Rapid Assay products including through the use of specialized Independent Sales Representatives (ISRs) and through a program to educate the marketplace through the preparation and publication of additional clinical studies"
mcmather
14/7/2018
08:55
Akers Biosciences (AKR) Earnings-Reaction to Keep an Eye http://crweworld.com/article/news-provided-by-globenewswire/735780/akers-biosciences-announces-q1-2018-earnings
danieldanj
13/7/2018
22:36
Akers Biosciences (AKR) News Out Just Now http://crweworld.com/article/news-provided-by-globenewswire/735768/akers-biosciences-files-restated-previously-issued-financial-statements-for-2017
danieldanj
30/6/2018
17:20
Still time to look at Akers Biosciences (AKR) - Upcoming Key Date http://crweworld.com/article/news-provided-by-globenewswire/720949/akers-biosciences-requests-temporary-suspension-of-trading-on-london-stock-exchange
danieldanj
29/6/2018
14:02
All you guys that ramped this POS Should say you are sorry
buywell3
20/6/2018
12:00
Is Walt getting ready for a knock at the door? "The Company is currently unable to quantify the level of recognisable revenues for the periods covered in these Reports, however it is expected that revenues will be lower than previously reported and losses for these periods will be greater".
mcmather
17/6/2018
17:20
How come there is a rns (see below) on Nasdaq but not yet on here? ---------- "...The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. On May 21, 2018, Akers announced that it was unable to file its Form 10-Q quarterly report with the SEC for the period ending March 31, 2018. The Company added that its internal review has expanded to include the “characterization of certain revenue recognition items . . . now includes certain transactions in previous quarters.” On May 22, 2018, shares of Akers fell more than 8% based on this news. On May 29, 2018, Akers announced that “Raymond F. Akers Jr., Ph.D. has resigned as a director of the Company with immediate effect.” Akers shares fell 33% the same day based on this announcement. On June 1, the Company released a letter to the SEC from Dr. Raymond Akers stating that he “resigned from the Board of Directors due to significant differences regarding the policies and practices of the Board of Directors, accounting and business practices of Management, and new Counsel.” If you are a shareholder who suffered a loss, click here to participate....."
algernon2
06/6/2018
07:42
Hmmmm: "On behalf of Ray Akers, we believe the language of the 8K regarding Ray is false, totally misleading, and such that will cause Ray to have to take corrective action. Ray is a whistleblower; the only reason there is an investigation regarding revenue recognition is because Ray refused to approve the 10K for 2017 and demanded an investigation. To say he is being “uncooperative” is utterly disingenuious and will not be tolerated".
mcmather
31/5/2018
20:36
Maybe at some point in time we may be invited to take part in some American "class action" depending upon what has been going on exactly.Thanks mcmather.
algernon2
31/5/2018
18:01
Algernon, buywell only posted here to reference another bio share - sbs possibly? - in the hope of gaining some interest with that. That's likely why you don't remember him / his posts. Re norbus; I think there was a month or so where he was invested but he definitely didn't "champion" akr. The threads on akr are easy enough to check. Each product had some potential at one time or another but walt 'knew' what he was doing when, cough, agreements would end in disputes. There's been some very unusual 'deals' here down the years and it will be interesting to see whether the authorities show an interest in walt's activities here.
mcmather
31/5/2018
15:27
Thanks to Buywell as well then. One would have done well to listen.
algernon2
Chat Pages: 156  155  154  153  152  151  150  149  148  147  146  145  Older
Your Recent History
LSE
AKR
Akers Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181213 06:35:22